Vander Lugt, Mark T <br/><br/>
ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death.  [electronic resource] 

 -  The New England journal of medicine  Aug 2013 
 - 529-39 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1533-4406 
<br/><br/><label>Standard No.: </label>10.1056/NEJMoa1213299  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Biomarkers--blood<br/>Graft vs Host Disease--blood<br/>Hematopoietic Stem Cell Transplantation--adverse effects<br/>Humans<br/>Interleukin-1 Receptor-Like 1 Protein<br/>Middle Aged<br/>Receptors, Cell Surface--blood<br/>Recurrence<br/>Risk Assessment--methods<br/>Risk Factors<br/>Transplantation, Homologous